Femoral Triangle + IPACK Blocks for ACL Reconstruction Analgesia

June 3, 2022 updated by: Sebastian Layera, University of Chile

A Randomised Comparison Between Combined Femoral Triangle Block+IPACK Block and Femoral Triangle Block for Anterior Cruciate Ligament Reconstruction Analgesia

An adequate balance between analgesia and motor function is an essential requirement to facilitate functional recovery and early discharge after anterior cruciate ligament (ACL) reconstruction surgery.

Proximal nerve blocks (i.e. femoral and sciatic nerve blocks) are associated with optimal analgesia, but they can cause muscle weakness, interfering with rehabilitation and increasing the risk of falls .

A recent randomized controlled trial concluded that, compared to mid-and distal ACB, a distal femoral triangle block (FTB) is associated with lower opioid consumption and improved postoperative analgesia for ambulatory ACL reconstruction.

In ACL reconstruction surgery there are other potential sources of pain not covered by a FTB, such as intra-articular structures (menisci, cruciate ligaments), posterior knee capsule and the graft donor site.

Evidence supporting the addition of an IPACK block to a FTB has been studied for patients undergoing total knee replacement, nonetheless, there is no trial analyzing the analgesic contribution of IPACK to a FTB in the context of ACL reconstruction surgery.

In this multicentric trial, the investigators set out to analyze the analgesic benefit of adding an IPACK block to a FTB.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • RM
      • Santiago, RM, Chile
        • Active, not recruiting
        • Clinica Alemana de Santiago
      • Santiago, RM, Chile
        • Recruiting
        • Hospital Clínico Universidad de Chile
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient scheduled to undergo anterior cruciate ligament reconstruction under general anesthesia with ipsilateral autologous graft.
  • Age between 18 and 65 years
  • American Society of Anesthesiologists classification 1-3
  • Body mass index between 19 and 35 (kg/m2)

Exclusion Criteria:

  • Adults who are unable to give their own consent
  • Pre-existing neuropathy (assessed by history and physical examination)
  • Coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets ≤ 100, International Normalized Ratio ≥ 1.4 or prothrombin time ≥ 50)
  • Renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine ≥ 100)
  • Hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases ≥ 100)
  • Allergy to local anesthetics (LAs), morphine or tramadol
  • Pregnancy
  • ACL revision surgery
  • Contralateral graft or any type of allograft
  • Chronic pain syndromes requiring opioid intake at home

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Femoral Triangle + IPACK block
Patients randomized to receive a combination of femoral triangle block and active IPACK block
Ultrasound-guided Femoral Triangle block with 20 mL of Bupivacaine 0.25% and IPACK block with 20 mL of Bupivacaine 0.25%
Active Comparator: Femoral Triangle block
Patients randomized to receive a combination of femoral triangle block and sham IPACK block
Ultrasound-guided Femoral Triangle block with 20 mL of Bupivacaine 0.25% and IPACK block with 20 mL of normal saline 0.9%

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative pain scores at 2 hours of arrival to Post Anesthesia Care Unit (PACU)
Time Frame: 2 hours after arrival to PACU
Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points
2 hours after arrival to PACU

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative static pain scores at 0 hours of arrival to PACU
Time Frame: 0 hours after arrival to PACU
Pain evaluated at rest in Numeric Rating Score from 0 to 10 points
0 hours after arrival to PACU
Post-operative static pain scores at PACU discharge
Time Frame: at discharge of PACU up to 2 hours postoperatively
Pain evaluated at rest in Numeric Rating Score from 0 to 10 points
at discharge of PACU up to 2 hours postoperatively
Post-operative static pain scores at 6 hours of arrival to PACU
Time Frame: 6 hours after arrival to PACU
Pain evaluated at rest in Numeric Rating Score from 0 to 10 points
6 hours after arrival to PACU
Post-operative static pain scores at 12 hours of arrival to PACU
Time Frame: 12 hours after arrival to PACU
Pain evaluated at rest in Numeric Rating Score from 0 to 10 points
12 hours after arrival to PACU
Post-operative static pain scores at 24 hours of arrival to PACU
Time Frame: 24 hours after arrival to PACU
Pain evaluated at rest in Numeric Rating Score from 0 to 10 points
24 hours after arrival to PACU
Post-operative dynamic pain scores at 0 hours of arrival to PACU
Time Frame: 0 hours after arrival to PACU
Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points
0 hours after arrival to PACU
Post-operative dynamic pain scores at PACU discharge
Time Frame: at discharge of PACU up to 2 hours postoperatively
Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points
at discharge of PACU up to 2 hours postoperatively
Post-operative dynamic pain scores at 6 hours of arrival to PACU
Time Frame: 6 hours after arrival to PACU
Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points
6 hours after arrival to PACU
Post-operative dynamic pain scores at 12 hours of arrival to PACU
Time Frame: 12 hours after arrival to PACU
Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points
12 hours after arrival to PACU
Post-operative dynamic pain scores at 24 hours of arrival to PACU
Time Frame: 24 hours after arrival to PACU
Pain evaluated during knee flexion in Numeric Rating Score from 0 to 10 points
24 hours after arrival to PACU
Femoral Triangle Block success assessment at 2 hours
Time Frame: 2 hours after arrival to PACU
Sensory block will be assessed with ice on the medial leg
2 hours after arrival to PACU
Incidence of opioid related adverse events
Time Frame: 24 hours after arrival to PACU
Incidence of adverse events related to opioid use (nausea/vomiting, pruritus, somnolence, respiratory depression, urinary retention)
24 hours after arrival to PACU
Intraoperative opioid consumption
Time Frame: From anesthesia induction to extubation
Total opioid use during intraoperative period
From anesthesia induction to extubation
PACU opioid consumption
Time Frame: from PACU arrival to discharge up to 2 hours postoperatively
total opioid consumption during PACU stay
from PACU arrival to discharge up to 2 hours postoperatively
Total opioid consumption
Time Frame: 6 hours, 12 hours and 24 hours after PACU arrival
Total opioid consumption
6 hours, 12 hours and 24 hours after PACU arrival
Nerve block complications
Time Frame: From nerve block performance up to 24 hours after PACU arrival
Incidence of nerve block complications (vascular puncture, puncture site erythema, hematoma, foot drop, LAST)
From nerve block performance up to 24 hours after PACU arrival
Lower limb tourniquet
Time Frame: from inflation of pneumatic device to tourniquet release
lower limb tourniquet duration
from inflation of pneumatic device to tourniquet release

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrea Gonzalez, MD, Clinica Alemana de Santiago

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2022

Primary Completion (Anticipated)

September 30, 2022

Study Completion (Anticipated)

October 15, 2022

Study Registration Dates

First Submitted

September 15, 2021

First Submitted That Met QC Criteria

September 26, 2021

First Posted (Actual)

October 5, 2021

Study Record Updates

Last Update Posted (Actual)

June 8, 2022

Last Update Submitted That Met QC Criteria

June 3, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on Bupivacaine Injection

3
Subscribe